Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Hepatocellular Carcinoma”

485 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 485 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Early research (Phase 1)Not Yet RecruitingNCT07077369
What this trial is testing

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT00319683
What this trial is testing

ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableStudy completedNCT02613156
What this trial is testing

Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma

Who this might be right for
Recurrent Hepatocellular Carcinoma
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Not applicableActive Not RecruitingNCT05148572
What this trial is testing

Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 101
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Large-scale testing (Phase 3)UnknownNCT04053972
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 377
Testing effectiveness (Phase 2)Study completedNCT04962958
What this trial is testing

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
CarcinomaCarcinoma, HepatocellularLiver Neoplasms+6 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Not applicableUnknownNCT05990959
What this trial is testing

Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

Who this might be right for
Hepatocellular Carcinoma RecurrentSurgery
China Medical University Hospital 800
Testing effectiveness (Phase 2)Ended earlyNCT05103904
What this trial is testing

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8+5 more
Emory University 3
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Not applicableUnknownNCT01713244
What this trial is testing

Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Southwest Hospital, China 150
Early research (Phase 1)Active Not RecruitingNCT03264664
What this trial is testing

Study of E7386 in Participants With Selected Advanced Neoplasms

Who this might be right for
Advanced Neoplasms
Eisai Inc. 60
Not applicableStudy completedNCT02728219
What this trial is testing

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

Who this might be right for
Recurrent Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Not applicableStudy completedNCT02643173
What this trial is testing

Hepatocellular Carcinoma Recurrence and Anesthesia

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Bundang Hospital 259
Next Page